Literature DB >> 19074167

Menstrual and hormonal alterations in juvenile systemic lupus erythematosus.

P B Medeiros1, M V Febrônio, E Bonfá, E F Borba, A D Takiuti, C A A Silva.   

Abstract

Menstrual cycles of 30 patients with juvenile systemic lupus erythematosus (JSLE) were compared with 30 age-matched controls. The mean age of patients with JSLE and controls was similar (17.4 +/- 3.2 vs 17.06 +/- 2.08 years, P = 0.66). The mean menarche age was higher in JSLE than controls (13.13 +/- 1.4 vs 11.56 +/- 1.5 years, P = 0.0008). On the contrary, the mean maternal menarche age was similar in both groups (P = 0.62). Menstrual abnormalities and longer length cycles were more frequently observed in JSLE than controls (63% vs 10%, P = 0.0001; 23% vs 0%, P = 0.0105, respectively). The median of follicle stimulating hormone was significantly higher in patients with JSLE compared with controls (4.6 vs 3.4 IU/L, P = 0.0207), and the median of progesterone was lower (32.5 vs 70 ng/mL, P = 0.0033). The median of luteinizing hormone was lower in patients with JSLE with menstrual abnormalities versus normal cycles (2.9 vs 5.5 IU/L, P = 0.019) and both had a high percentage of decreased progesterone levels (63% vs 73%, P = 0.70). Our findings support the notion that menstrual disturbances are frequent and may be associated with pituitary dysfunction leading to a decreased progesterone production. We also reported that in spite of premature ovarian failure being a rare event in JSLE the follicular reserve seems to be low regardless of intravenous cyclophosphamide treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19074167     DOI: 10.1177/0961203308094652

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

Review 1.  Risk factors of systemic lupus erythematosus flares during pregnancy.

Authors:  Luis J Jara; Gabriela Medina; Pilar Cruz-Dominguez; Carmen Navarro; Olga Vera-Lastra; Miguel A Saavedra
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

3.  Rheumatoid arthritis: The effect of RA and medication on female fertility.

Authors:  Monika Ostensen
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

4.  Menstrual cycle changes in women with inflammatory bowel disease: a study from the ocean state Crohn's and colitis area registry.

Authors:  Sumona Saha; Ying-Qi Zhao; Samir A Shah; Silvia Degli Esposti; Sheldon Lidofsky; Sana Salih; Renee Bright; Meaghan Law; Heather Moniz; Nicole Flowers; Marjorie Merrick; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

Review 5.  Adult outcomes of childhood-onset rheumatic diseases.

Authors:  Aimee Hersh; Emily von Scheven; Ed Yelin
Journal:  Nat Rev Rheumatol       Date:  2011-04-12       Impact factor: 20.543

6.  Altered IgG autoantibody levels and CD4(+) T cell subsets in lupus-prone Nba2 mice lacking the nuclear progesterone receptor.

Authors:  Alan H Wong; Nalini Agrawal; Grant C Hughes
Journal:  Autoimmunity       Date:  2015-04-10       Impact factor: 2.815

Review 7.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

8.  Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea.

Authors:  Clovis A Silva; Maria E J Deen; Marilia V Febrônio; Sheila K Oliveira; Maria T Terreri; Silvana B Sacchetti; Flavio R Sztajnbok; Roberto Marini; Maria V Quintero; Blanca E Bica; Rosa M Pereira; Eloisa Bonfá; Virginia P Ferriani; Teresa C Robazzi; Claudia S Magalhães; Maria O Hilário
Journal:  Rheumatol Int       Date:  2010-03-21       Impact factor: 2.631

9.  Diminished ovarian reserve in Behçet's disease patients.

Authors:  Andrea R S Mont'Alverne; Lucas Y S Yamakami; Célio R Gonçalves; Edmund C Baracat; Eloisa Bonfá; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2014-05-31       Impact factor: 2.980

10.  Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients.

Authors:  Renato B Tomioka; Gabriela R V Ferreira; Nadia E Aikawa; Gustavo A R Maciel; Paulo C Serafini; Adriana M Sallum; Lucia M A Campos; Claudia Goldestein-Schainberg; Eloisa Bonfá; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2018-07-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.